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Abstract: Cancer of the breast is the second most common human neoplasm, accounting for approximately one quarter of 
all cancers in females after cervical carcinoma. Estrogen receptor (ER), Progesteron receptor and human epidermal 
growth factor receptor (HER-2/neu) expressions play an important role in diagnosis and prognosis of breast carcinoma. 
Tissue microarray (TMA) technique is a high throughput technique which provides a standardized set of images which are 
uniformly stained, facilitating effective automation of the evaluation of the specimen images. TMA technique is widely 
used to evaluate hormone expression for diagnosis of breast cancer. If one considers the time taken for each of the steps in 
the tissue microarray process workflow, it can be observed that the maximum amount of time is taken by the analysis step. 
Hence, automated analysis will significantly reduce the overall time required to complete the study. Many tools are 
available for automated digital acquisition of images of the spots from the microarray slide. Each of these images needs to 
be evaluated by a pathologist to assign a score based on the staining intensity to represent the hormone expression, to 
classify them into negative or positive cases. Our work aims to develop a system for automated evaluation of sets of 
images generated through tissue microarray technique, representing the ER expression images and HER-2/neu expression 
images. Our study is based on the Tissue Microarray Database portal of Stanford university at http://tma.stanford.edu/cgi-
bin/cx?n=her1, which has made huge number of images available to researchers. We used 171 images corresponding to 
ER expression and 214 images corresponding to HER-2/neu expression of breast carcinoma. Out of the 171 images 
corresponding to ER expression, 104 were negative and 67 were representing positive cases. Out of the 214 images 
corresponding to HER-2/neu expression, 112 were negative and 102 were representing positive cases. Our method has 
92.31% sensitivity and 93.18% specificity for ER expression image classification and 96.67% sensitivity and 88.24% 
specificity for HER-2/neu expression image classification. 
Keywords:  Automated breast cancer diagnosis, Decision support systems, Image analysis, Tissue microarray, staining 
expression quantification. 
1. INTRODUCTION 
  Cancer of the breast is the 2
nd most common human 
neoplasm, accounting for approximately one quarter of all 
cancers in females after cervical carcinoma. Estrogen 
receptor (ER), Progesteron receptor and human epidermal 
growth factor receptor (HER-2/neu) expressions play an 
important role in diagnosis and prognosis of breast 
carcinoma. It is observed that patients showing higher 
receptor expressions have delayed recurrence and longer 
survival rates compared to those lacking the receptor 
expressions [1]. 
  Immunohistochemical evaluation of hormone receptor 
expression in tumor cell nuclei is an integral part of routine 
breast cancer diagnosis and provides important information 
with relevance for prognosis and choice of therapeutic 
approach. The TMA technique enables hundreds of tissue   
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cores to be probed simultaneously by many different 
antibodies in a single run to evaluate the use of the 
antibodies as biomarkers, by using immunohistochemistry. 
Thus, TMA is used to provide fast and standardized images 
of the specimen. It facilitates high throughput analysis while 
minimizing tissue and reagent waste [2]. 
  The basic tissue array technique is introduced by 
Kononen [3]. Using a tissue arraying instrument, a tissue 
core is removed from the area of interest from the 
histopathology block called the ‘donor block’ using a thin 
walled needle. The thin walled needle is held in an X-Y 
precision guide and is used to place the core into an empty 
paraffin block, called the ‘recepient block’, at a specifically 
designated location. This process can be repeated to embed 
thousands of such samples into the recipient blocks [4]. 
  The authors in [5] describe the procedure for TMA 
construction. High sampling accuracy and screening 
reliability can be maintained by including multiple cores 
from each patient specimen. Also, four to six samples from 
the same morphologic area can be inserted into the array so 
that it compensates for the losses occurring during Datamining Approach for Automation of Diagnosis of Breast Cancer  The Open Medical Informatics Journal, 2010, Volume 4    87 
processing. Thus TMA facilitates combining hundreds of 
specimens of tissue onto a single slide for analysis. Having 
such a large number of spots on one single slide calls for a 
fast and efficient means of scoring and analyzing any 
biomarker data, so that a meaningful statistical analysis can 
be done. However, this kind of high throughput technique 
makes it difficult to manage data in each phase, from design 
to analysis and final report of results, which makes the 
software support almost inevitable. The basic technical 
aspects of TMA production, current and potential future 
applications are discussed in [6]. 
  If one considers the time taken for each of the steps in the 
TMA process workflow, it can be observed that the 
maximum amount of time is taken by the analysis step. 
Hence, automated construction of TMA will probably have 
little impact whereas automated analysis will significantly 
reduce the overall time required to complete the study. 
  Reading the TMA spots in an orderly, reproducible and 
reliable manner is a quite difficult task to do manually since 
keeping track of the precise position of each spot in a slide 
with more than 300 spots is in itself highly challenging. The 
BLISS imaging system from Bacus Laboratories and ACIS 
 
Fig. (1). TMA construction (From http://www.tissuearray.org/yale/tisarray.html). 
 
Fig. (2). ACIS Grid for automated identification of spots on a slide (From a lecture slide available at 
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system of Chromavision  [7] are the digital solutions for 
automating the tasks of scanning and acquiring all spots on 
the slide in one go. ‘TMAScore’ marketed by Bacus 
Laboratories, facilitates scanning into virtual slides, placing 
the slide on a network, tracking and recording the scores 
from tissue cores etc. 
  For the proper organization and analysis of spots, a novel 
relational database for TMA analysis has been described 
using Adobe Photoshop for image-editing and Microsoft 
Excel for recording core coordinates and performing scoring 
in [8]. In this work, the digital images of individual cores are 
stored in a specified folder of the computer. The pattern of 
grids present in the TMA slide is represented in rows and 
columns of MS Excel worksheet. The hyperlinks for each of 
the grids are inserted in such a way that the hyperlink 
connects to the specific core and opens the corresponding 
image for further evaluation. This method is particularly 
useful when the number of images in the database does not 
exceed 150. 
  For high-throughput analysis, excellent set of software 
tools have been developed at Stanford University. The 
description of these software tools is available in [9]. The 
Tissue Microarray Database (TMAD; http://tma.stanford. 
edu/)
  at Stanford University is a web-based system that 
provides researchers
  with tissue microarray design tools, 
image scoring and annotation
  tools, data sharing mecha-
nisms, an image archive, an analysis
 toolset and publication 
mechanism. These investigators used the BLISS System for 
generating a database of images. The software called ‘TMA 
Deconvoluter’ is used to reformat the Excel data into a text 
file so that it is suitable for cluster analysis by the use of 
‘Cluster’ and ‘TreeView’ programs. This analyzes the 
relatedness within tumor subsets depending on the 
immunohistochemical biomarker profile. The TreeView 
software allows for rapid transformation of immunohisto-
chemistry data into a format that can be used for cluster 
analysis by generating dendrograms. The ‘Stain Finder’ 
program acts as a hyperlink to the corresponding images 
archived in the database. This facilitates rapid retrieval of the 
immunoprofile of the archived cases. An on-line 
demonstration
  of this system is available at http://genome-
www.stanford.edu/TMA/explore.shtml.
 
 Camp  et al. have developed a system called AQUA 
(Automated Quantitative Analysis) [10] which uses fluore-
scent imaging to quantify TMA cores at the sub-cellular 
level, to provide a score that is directly proportional to the 
number of molecules expressed per unit area. An open-
source java-based software called "TMAJ" is available from 
the website of the Johns Hopkins University TMA core 
facility [11] (http://tmaj.pathology.jhmi.edu/). This helps in 
recording pathology data as well as core tracking and 
scoring. Heyer et al. [12]  have developed an integrated 
microarray data analysis tool called MAGIC which has been 
designed to explore and analyze all types of gene expression 
data. 
 TMA provides large standardized dataset of 
immunohistochemically stained images. The interpretation 
of these images relies solely on subjective visual estimates, 
yielding qualitative or semi quantitative results. Each of the 
spots of the tissue microarray has to be evaluated by a 
pathologist for assigning scores based on staining intensity to 
represent the antigen expression.  [13] considers three 
different staining scores, maximum staining intensity, 
percentage of cells staining positive and percentage of cells 
staining with maximum intensity. This is a subjective and 
time consuming task. 
  The software support for automation of quantification of 
antigen expression in each of the spots is not enough. 
Attempts to automate the evaluation of antigen expression 
are reported in many studies [14-20], but they just identify 
the area of positive staining but do not discriminate the 
difference in depth of staining, which is very crucial for the 
scoring of spots. 
  Through this work, we attempt to automate the 
evaluation of the ER and HER-2/neu expression for 
diagnosis of breast cancer providing objective, fast and 
repeatable analysis. 
2. MATERIALS USED 
  Our study is based on the Tissue Microarray Database 
portal of Stanford university at http://tma.stanford.edu/cgi-
bin/cx?n=her1,  which has made huge number of images 
available to researchers. We downloaded 171 images 
corresponding to estrogen receptor (ER) expression and 214 
images corresponding to human epidermal growth factor 
receptor (HER-2/neu) expression of breast carcinoma. Out of 
the 171 images corresponding to ER expression images, 104 
were negative and 67 were representing positive cases. Out 
of the 214 images corresponding to HER-2/neu expression 
images, 112 were negative and 102 were representing 
positive cases. For the quantification of the staining 
expression, an in-house developed image analysis software 
named ‘TissueQuant’ was used, which works on the set of 
images and generates an Excel sheet with the relevant color 
scores. These color scores along with other parameters were 
passed to a neural network for automation of the 
classification of images as negative or positive cases. 
3. METHOD 
  The images were analyzed using the TissueQuant 
software which was specifically developed for the staining 
expression quantification. The TissueQuant algorithm works 
as follows. As a first step, the color image which is 
represented in the RGB color space is converted into HSI 
color space. This is done because RGB color space does not 
represent the colors as perceived by the human eye. The 
Hue, Saturation and Intensity components of every pixel 
with coordinates (i, j) are represented as H(i, j), S(i, j) and 
I(i, j) respectively. These components are studied in 
comparison with the reference color and are assigned 
appropriate scores. The formula used for obtaining the score 
is based on how close the hue, saturation and intensity 
components are to the hue (Hc) saturation (Sc) and intensity 
(Ic) components of the color of interest. The widths of the 
Gaussian weighting functions are decided by the different 
ranges for the hue (Hw), saturation (Sw) and intensity (Iw) 
components. These values decide the range of shades of the 
color which should be given a score. The ER and HER-2/neu 
expressions take up brown staining for the breast carcinoma 
positive cells. Hence we choose the centres and widths for 
hue, saturation and intensity for this color as reference and Datamining Approach for Automation of Diagnosis of Breast Cancer  The Open Medical Informatics Journal, 2010, Volume 4    89 
obtain the Gaussian weighting function to obtain the score 
for stained pixels. 
  The score for the pixel at (i, j) is obtained from the 
weighting functions for the three components as follows. The 
score for how close the hue of pixel (i, j) is to the reference 
color is represented as IH(i, j), score for how close the 
saturation is to the reference color is represented as IS(i, j) and 
score for how close the intensity is to the reference color is 
represented as II(i, j). One also has to keep in mind that colors 
at the end of the hue scale are similar to colors at the 
beginning of the scale. Therefore, the function IH(i, j) has to 
wrap around at the limits of the scale. The corresponding 
equation for a scale [0, 1] is shown below. The cumulative 
score I(i, j) is given as the product of the three components 
represented as follows. 
I(i, j)= IH(i, j)Is(i, j)II(i, j) 
IH i, j () = e
 Hi ,j () HC1 ()
2
HW
2
+e
 Hi ,j () HC ()
2
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2
+e
 Hi ,j () HC+1 ()
2
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2
 
IS i, j () = e
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2
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II i, j () = e
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2
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  The scores for all the pixels were calculated as mentioned 
above. The mean of the pixel values (Mean) is taken as one 
feature used for classification. The image with strong 
response to the hormone expression in a very small area also 
represents a positive diagnosis. Hence, another feature called 
Mean-Max is calculated as the mean of the highest fifteen 
pixel scores which represent strong response to the stain. 
These features along with the other color features namely 
hue variance, mean hue and mean saturation were also used 
for classification. Hue variance is calculated by taking only 
the hue component of all the pixels and calculating their 
variance. Mean saturation is obtained by taking the mean of 
the saturation components of all the pixels. A back 
propagation neural network was used for the classification of 
the images into negative and positive cases. These five 
parameters namely Mean color score, Mean–Max, Hue 
variance, Mean saturation and Mean hue were fed to the 
neural network which classifies the cases as negative or 
positive. 
  In a feed forward neural network, neurons are arranged in 
layers, with the first layer taking the inputs and the last layer 
producing the outputs. Neurons are connected from one layer 
to the next with different strengths called weights. No 
connections are allowed between neurons in the same layer. 
Neurons are not connected to any other neuron beyond those 
in the next layer. Each neuron in one layer is connected to 
every neuron in the next layer. This way, the information is 
fed forward in the network. In the case of feed forward 
networks, supervised learning algorithms are used for 
training the network. In this case, a back propagation 
algorithm is used for the training purpose. 
  The network is trained by presenting the pattern at the 
input layer. The actual output and the desired output are 
compared to obtain the error measure. Back propagation 
algorithm then modifies the weights of the connections 
between the neurons so as to minimize this measure. 
  For the classification of HER-2/neu expression images, a 
feed forward backpropagation network with 2 layers as 
shown in Fig. (3), was used. 150 images out of which 78 
representing negative and 72 representig positive cases were 
used for training the neural network. 64 images out of which 
34 representing negative and 30 representing positive cases 
were used for the testing purpose. 
  The basic unit of time delay neural network (TDNN) is 
shown in Fig. (4). In this model, a delay element is 
introduced as shown in the figure below, represented by z
-1. 
The inputs X1(t),...,XN(t) represent the N dimensions of the 
vector  at time t and (D+1) is the number of the 
 
Fig. (3). Backpropagation ANN used for classification of HER-2/neu expression images. 
Output 
Mean-Max  
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Hue variance  
Mean hue  
Mean saturation  
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successive vectors  which define the temporal window 
size to which the neuron reacts. Each delay element is 
associated with different weights. Thus each of the N inputs 
X1(t),...,XN(t), are multiplied by D weights Wj(0),...,Wj(D), 
(j=1,...,N) and the weighted sum, Y, is passed through the 
sigmoid function. In this way, a TDNN unit relates and 
compares current input to the past history of events [21]. 
 
Fig. (4). A Timedelay neural network architecture. 
  For the classification of ER expression images, a time 
delay backpropagation network with 2 layers having 5 
neurons in the first layer was used. 101 images out of which 
60 representing negative and 41 representig positive cases 
were used for training the neural network. 70 images out of 
which 44 representing negative and 26 representing positive 
cases were used for the testing purpose. 
4. RESULTS 
  The results of classification of the images are 
summarised in the followig tables. Table 1 shows the results 
of image classification for the positive and negative cases of 
ER expression. Similarly, Table 2 shows the results of image 
classification for the positive and negative cases of HER-
2/neu expression. Table 3 shows the details of the training 
and testing data and the results of classification for both ER 
expression and HER-2/neu expression images by the neural 
networks. It can be observed that the neural networks can 
classify with an accuracy more than 92% in both the cases. 
Table 4 shows the results of sensitivity, specificity, positive 
predictive value and negative predictive values of the 
classification of the ER expression and HER expression 
images. It can be observed that the neural networks can 
classify the images with more than 92% sensitivity for both 
the ER and HER-2/neu expression images. 
5. DISCUSSION 
  In this paper we present a system to automate 
classification of images of immunohistochemically stained 
tissues for diagnosis of breast cancer. The technique is based 
on the quantification of the hormone expression. The 
hormone expression is represented by the brown staining in 
the stained tissue images. We take into consideration the 
depth of the color also along with the area to quantify the 
hormone expression. Our method can classify the images 
with approximately 90% specificity and above 92% 
sensitivity. 
Table 1.  Results for ER-Expression Image Classification 
 
 Positive  Negative  Total 
Test positive  24  3  27 
Test negative  2  41  43 
Total 26  44  70 
 
Table  2.  Results for HER-2/neu Expression Image 
Classification 
 
 Positive  Negative  Total 
Test positive  29  4  33 
Test negative  1  30  31 
Total 30  34  64 
 
Table 3.  Image Classification Results for ER and HER-2/neu 
Expressions 
 
 
Number of Data  
Used for  
Training 
Number of Data  
Used for  
Testing 
Accuracy  
(%) 
ER expression  101 70  92.86 
HER-2/neu  
expression 
150 64  92.18 
 
  Automation has been tried at different stages of the TMA 
process by various groups [22-28].  Automation of 
construction of TMA has been quite satisfactory. However, 
most of these studies depend on manual scoring of the 
images by a pathologist. This is a very laborious process, 
given the high throughput feature of the TMA technique. 
The manual evaluation is one of the major bottlenecks of the 
TMA process flow which affects the time taken for the 
completion of the study very significantly. In this work, we 
have attempted to overcome this bottleneck. 
  Traditional techniques for staining quantification rely
 
solely on subjective visual estimates, yielding only 
Table 4.  Results of Sensitivity, Specificity, Positive Predictive Accuracy and Negative Predictive Accuracy of Classification of ER 
and HER-2/neu Expression Images 
 
  True 
Positive 
True 
Negative 
False 
Positive 
False 
Negative 
Sensitivity 
(%) 
Specificity 
(%) 
Positive Predictive 
Value (%) 
Negative Predictive 
Value (%) 
ER expression  24  41  3  2  92.31  93.18  88.89  95.35 
HER-2/neu expression  29  30  4  1  96.67  88.24  87.88  96.77 Datamining Approach for Automation of Diagnosis of Breast Cancer  The Open Medical Informatics Journal, 2010, Volume 4    91 
qualitative
  or at best semi quantitative results. The semi 
quantitative approach is laborious and time consuming and 
the evaluation is very subjective. A score ranging from 0 
representing no staining, to a score of 4 representing very 
intensive staining is generally used by most of the 
pathologists. Distinguishing between the positive and 
negative results is done by studying the percentage of tumor 
cells which are positive, the cut off being arbitrarily defined 
between 5 and 45% [29-32]. Other studies [33-35] have 
applied semi quantitative scores to
  assess nuclear staining 
intensity as a marker of the number
  of receptors per cell. 
However, most of these scoring
 systems are cumbersome and 
are highly subjective, thus leading to high
  interobserver 
variability. In the case of images generated through TMA 
technique automation of image analysis becomes extremely 
important so as to match with high throughput of TMA. The 
high throughput feature of the TMA not only increases the 
productivity but also provides statistically significant results. 
  To provide more standardized data
 for the quantification, 
diverse
  computerized image analysis systems have been 
employed and were
  found to correlate well with semi 
quantitative histological scoring
  methods and with 
biochemical data [36-38]. However, these suffer from high 
cost and complexity due to the need for software and specific 
hardware investments. Hence, the use of these systems in the 
routine diagnostic laboratories is limited [39]. 
  Digital image analysis techniques have been introduced 
to obtain more objective, reproducible and accurate results. 
Various kinds of solutions ranging from general purpose and 
inexpensive software to specific and expensive software are 
available to quantify the specific substance present. [15] uses 
the general purpose image processing software named 
‘Metaview’ for staining quantification in which suitable 
threshold values for Red (R), Green (G) and Blue (B) 
components are selected to choose the stained area. The area 
representing positively stained region gives the measure of 
the substance under study. [16] and [17] make use of Lucia 
software in which quantification of stain is based on the 
measure of optical density. [19] uses threshold and area 
measurement approach. Some more image analysis systems 
which are available to do this task are BioQuant Nova Prime, 
Image Pro Plus (Media Cybernetics) and EMPIX Imaging 
solutions. BioQuant Nova Prime is an advanced image 
analysis tool designed for biomedical research. An 
automated microscope slide analysis tool named Ariol SL 
50, uses three bright field filters to acquire monochrome 
images and applies cell masking templates to perform area 
analysis. Analysis of images in all these applications is based 
on either threshold and area measurement or the change in 
optical density. Moreover, selecting appropriate R, G and B 
thresholds to suitably select shades of a particular color is 
not always possible. When the substance under study is 
present in lower concentrations, it stains with lighter shades 
and when present at higher concentrations it stains with 
stronger shades. Some other components present in the 
specimen other than the substance under study could also 
take up a small degree of staining. Thus, it is important to 
detect weak specific staining while rejecting non-specific 
staining to avoid false positive detections. In such cases, the 
approach of threshold and area measurement fails. Also, 
when a tissue section is studied for a particular substance, 
other components present in the section may also take up the 
stain, expressing different colors. Even these kinds of 
expressions could contribute to the change in optical density. 
Hence, there is a need to eliminate such contributions from 
other components of the tissue section and hence the change 
in optical density can not be a suitable measure of staining 
expression. 
  [40] used SAMBA 4000 image analysis system for 
quantification of hormone receptor expression. In this work, 
the positive cell surface, and integrated and mean optical 
densities and the histograms of integrated optical density 
were compared. [41] developed semi-automatic system to 
quantify estrogen and progesterone receptor 
immunoreactivity in human breast cancer. [42] used 
WinROOF with macroinstructions for analyzing each 
captured area. [39] used Adobe Photoshop-based image 
analysis to quantify hormone receptor expression in breast 
cancer. The feature
 selection was done with the Magic Wand 
tool which could reliably select all immunostained
  nuclei. 
The nuclear immunostaining index was calculated as 
difference between nuclear and background immunostaining 
intensity. 
  It has been well established that the quantification of 
hormone receptor expression beyond classifying as positive / 
negative could be very useful in providing more insight into 
the disease and the survival analysis [43]. Many studies have 
used the positive vs negative modes of evaluation based on 
arbitrary cut off of percentage of stained nuclei for survival 
analysis. However, some groups have used subjective 
scoring of nuclear intensity for survival analysis [33,44]. 
DeSombre  et al. in [45] report that correlation
  between 
nuclear staining of ER and both disease-free and overall
 
survival is statistically significant. Reiner and co-workers 
[33] showed that those patients
  had the best prognosis in 
whom nuclear immunostaining of ER
 was strongest. Esteban 
and co-authors [46] showed that immunostaining intensity 
could discriminate
  groups of patients with statistically 
different risks for disease
 relapse and death using a dedicated
 
image analysis system for quantification of immunocyto-
chemical
 studies [39]. 
  The proposed image analysis system evaluates the 
intensity of the hormone expression based on the color 
scores provided by the TissueQuant algorithm, which is used 
to classify the cases as positive or negative. As an extension 
of this work, it would be useful to evaluate the color scores 
provided by the TissueQuant algorithm to correlate with the 
prognosis and survival analysis. 
6. CONCLUSION 
  Through this work, a method for efficient datamining of 
pathological images for diagnosis of breast cancer from 
tissue microarray technique is discussed. Tissue microarray 
provides such a high throughput that handling them 
individually is quite laborious. Also, it is observed that the 
analysis phase in the TMA workflow is where the maximum 
time is spent. This work proposes to automate the 
classification of images by applying image analysis 
algorithm to quantify the ER and HER-2/neu antigen 
expression in the images and thus classify the images into 
negative or positive cases. In the present work, we have 
considered the images representing the ER and HER-2/neu 
expressions evaluation for breast carcinoma cases. The same 92    The Open Medical Informatics Journal, 2010, Volume 4  Prasad et al. 
approach could be used for other studies based on 
immunohistochemical stains in which the antigen expression 
could be evaluated based on staining intensity. For this work, 
we used a total of 171 ER expression images and 214 HER-
2/neu expression images. We have shown that the proposed 
method has 92.31% sensitivity and 93.18% specificity for 
ER classification and 96.67% sensitivity and 88.24% 
specificity for HER-2/neu classification. This way, this work 
can contribute to match up with the high throughput of the 
imaging technology to bring in lot of advancements in the 
area of medical research. 
REFERENCES 
[1]  Almasri NM, Hamad MA. Immunohistochemical evaluation of 
human epidermal growth factor receptor 2 and estrogen and 
progesterone receptors in breast carcinoma in Jordan. Breast 
Cancer Res 2005; 7: R598-R604. 
[2]  Website of University of Pittsburgh Cancer Institute, Tissue 
MicroArray (TMA) Laboratory. Available from: http://www.upci. 
upmc.edu/tarps/index.cfm [Accessed on 25.08.2009]. 
[3]  Kononen J, Bubendorf L, Kallioniemi A, Barlund M, et al. Tissue 
microarray for high-throughput molecular profiling of tumor 
specimens. Nat Med 1998; 4: 844-7. 
[4]  Shergill SI, Arya M. Tissue microarrays. Expert Rev Mol Diagn 
2004; 4(4): 421-3. 
[5]  Venkataraman G, Ananthanaranayanan V. Tissue microarrays: 
Potential in the Indian subcontinent. Indian J Cancer 2005; 42(1): 
9-14. 
[6]  Packeisen J, Korsching E, Herbst H, Boecker W, Buerger H. 
Demystified... Tissue microarray technology. J Clin Pathol: Mol 
Pathol 2003; 56: 198-204. 
[7]  Homepage of ACIS system of Chromavisoin: Product description. 
Available from: http://www.bioresearchonline.com/product.mvc/ 
Automated-Cellular-Imaging-System-0002 [Accessed on 25.08. 
2009]. 
[8]  Shaknovich R, Celestine A, Yang L, Cattoretti G. Novel relational 
database for tissue microarray analysis. Arch Pathol Lab Med 
2003; 127: 492-4. 
[9]  Liu CL, Prapong W, Natkunam Y, Alizadeh A, et al. Software 
tools for high-throughput analysis and archiving of immunohisto-
chemistry staining data obtained with tissue microarrays. Am J 
Pathol 2002; 161: 1557-65. 
[10]  Camp RL, Charette LA, Rimm DL. Validation of tissue microarray 
technology in breast carcinoma. Lab Invest 2000; 80: 1943-9. 
[11]  The TMAJ Software Project. Website of John Hopkins University. 
Available from: http://tmaj.pathology.jhmi.edu/ [Accessed on 
25.08.2009]. 
[12]  Heyer LJ, Moskowitz DZ, Abele JA, Karnik P, et al. MAGIC Tool: 
integrated microarray data analysis. Oxford Univ J 2005; 21(9): 
2114-5. 
[13]  Liu X, Minin V, Huang Y, Seligson DB, Horvath S. Statistical 
methods for analyzing tissue microarray data. J Biopharm Stat 
2004; 14(3): 671-85. 
[14]  Nielsen TO, Hsu FD, O’Connell JX, et al. Tissue microarray 
validation of epidermal growth factor receptor and SALL2 in 
synovial sarcoma with comparison to tumors of similar histology. 
Am J Pathol 2003; 163: 1449-56. 
[15]  Diaz Encarnacion MM, Griffin MD, Slezak JM, et al. Correlation 
of quantitative digital image analysis with the glomerular filtration 
rate in chronic allograft nephropathy. Am J Transplant 2004; 4(2): 
248. 
[16]  Pauschinger M, Knopf D, Petschauer S, et al. Dilated cardiomyo-
pathy is associated with significant changes in collagen Type I/III 
ratio. Circulation 1999; 99: 2750-6. 
[17]  Soukupova J, Albrechtova J. Image analysis – tool for quantifi-
cation of histochemical detections of phenolic compounds, lignin 
and peroxidases in needles of Norway spruce. Biol Plant 2003; 
46(4): 595-601. 
[18]  Puolakkainen PA, Brekken RA, Muneer S, Sage EH. Enhanced 
growth of pancreatic tumors in SPARC-Null Mice is associated 
with decreased deposition of extracellular matrix and reduced 
tumor cell apoptosis. Mol Cancer Res 2004; 2: 215-24. 
[19]  Niendorf A, Rath M, Wolf K, et al. Morphological detection and 
quantification of lipoprotein (a) deposition in atheromatous lesions 
of human aorta and coronary arteries. Virchows Arch Pathol Anat 
1990; 417: 105-11. 
[20]  De Boer WI, Hiemstra PS, Sont JK, et al. Image analysis and 
quantification in lung tissue. Clin Exp Allergy 2001; 31: 504-8. 
[21]  Jedra M, El Khattabi N, Limouri M, Essaid A. Recognition of seed 
varieties using a time-delay neural network: analysis of 
electrophoretic images. Comput Electron Agric 1999; 22(1): 1-10. 
[22]  Lingle WL, Riehle DL, Lohse CM, Murphy LL, et al. Automated 
image analysis for the quantification of immunostains in prostate 
tissue microarrays. Proc Am Assoc Cancer Res 2004; 45. 
[23]  Bova G. Web-based tissue microarray image data analysis: Initial 
validation testing through prostate cancer Gleason grading. Hum 
Pathol 2001; 32(4): 417-27. 
[24]  Takikita M, Chung JY, Hewitt SM. Tissue microarrays enabling 
high-throughput molecular pathology. Curr Opin Biotechnol 2007; 
18(4): 318-25. 
[25]  Romero E, Thallinger GG, Baumgartner K, et al. TAMEE: data 
management and analysis for tissue microarrays. BMC Bioinform-
atics 2007; 8: 81. 
[26]  Hsu FD, Nielsen TO, Alkushi A, et al. Tissue microarrays are an 
effective quality assurance tool for diagnostic immunohisto-
chemistry. Mod Pathol 2002; 15(12): 1374. 
[27]  Della Mea V, Bin I, Pandolfi M, Di Loreto C. A web-based system 
for tissue microarray data management. Diagn Pathol 2006; 1: 36. 
[28]  Marinelli RJ, Montgomery K, Liu CL, et al. The Stanford tissue 
microarray database. Nucleic Acids Res 2008; 36: D871-D877. 
[29]  Raymond WA, Leong AS. Oestrogen receptor staining of paraffin-
embedded breast carcinomas following short fixation in formalin: a 
comparison with cytosolic and frozen section receptor analyses. J 
Pathol 1990; 160: 295-303. 
[30]  Pertschuk LP, Feldman JG, Kim Y-D, et al. Estrogen receptor 
immunocytochemistry in paraffin embedded tissues with ER1D5 
predicts breast cancer endocrine response more accurately than 
H222Sp-gamma in frozen sections or cytosol-based ligand-binding 
assays. Cancer 1996; 77: 2514-9. 
[31]  Molino A, Micciolo R, Turazza M, et al. Estrogen receptors in 699 
primary breast cancers: a comparison of immunohistochemical and 
biochemical methods. Breast Cancer Res Treat 1995; 34: 221-8. 
[32]  Veronese SM, Barbareschi M, Morelli L, et al. Predictive value of 
ER1D5 antibody immunostaining in breast cancer. Appl Immuno-
histochem 1995; 3: 85-90. 
[33]  Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz 
R. Immunocytochemical localization of estrogen and progesterone 
receptor and prognosis in human primary breast cancer. Cancer Res 
1990; 50: 7057-61. 
[34]  Remmele W, Schicketanz KH. Immunohistochemical determi-
nation of estrogen and progesterone receptor content in human 
breast cancer. Computer-assisted image analysis (QIC score) vs 
subjective grading (IRS). Pathol Res Pract 1993; 189: 862-6. 
[35]  Detre S, Saclani-Jotti G, Dowsett M. A "quickscore" method for 
immunohistochemical semiquantitation: validation for oestrogen 
receptor in breast carcinomas. J Clin Pathol 1995; 48: 876-8. 
[36]  Auger M, Katz RL, Johnston DA, Sneige N, Ordonez NG, Fritsche 
H. Quantitation of immunocytochemical estrogen and progesterone 
receptor content in fine needle aspirates of breast carcinoma using 
the SAMBA 4000 image analysis system. Anal Quant Cytol Histol 
1993; 15: 274-80. 
[37]  Aziz DC. Quantitation of estrogen and progesterone receptors by 
immunocytochemical and image analyses. Am J Clin Pathol 1992; 
98: 105-11. 
[38]  Santeusanio G, Mauriello A, Schiaroli S, et al. Densitometric and 
morphometric study of immunocytochemical estrogen receptors 
detection in breast carcinomas. Pathol Res Pract 1992; 188: 478-83. 
[39]  Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM. 
Application of photoshop-based image analysis to quantification of 
hormone receptor expression in breast cancer. J Histochem 
Cytochem 1997; 45: 1559-66. 
[40]  Charpin C, Andrac L, Habib MC, et al. Immunodetection in fine-
needle aspirates and multiparametric (SAMBA) image analysis. 
Receptors (monoclonal antiestrogen and antiprogesterone) and 
growth fraction (monoclonal Ki67) evaluation in breast 
carcinomas. Cancer 1989; 63(5): 863-7. 
[41]  Sharangpani GM, Joshi AS, Porter K, et al. Semi-automated 
imaging system to quantitate estrogen and progesterone receptor Datamining Approach for Automation of Diagnosis of Breast Cancer  The Open Medical Informatics Journal, 2010, Volume 4    93 
immunoreactivity in human breast cancer. J Microsc 2007; 226(Pt 
3): 244-55. 
[42]  Hatanaka Y, Hashizume K, Nitta K, Kato T, Itoh I, Tani Y. 
Cytometrical image analysis for immunohistochemical hormone 
receptor status in breast carcinomas. Pathol Int 2003; 53(10): 693-
9. 
[43]  Kamby C, Rasmussen BB, Kristensen B. Oestrogen receptor status 
of primary breast carcinomas and their metastases. Relation to 
pattern and spread and survival after recurrence. Br J Cancer 1989; 
60: 252-7. 
[44]  Esteban JM, Ahn C, Mehta P, Battifora H. Biologic significance of 
quantitative estrogen receptor immunohistochemical assay by 
image analysis in breast cancer. Am J Clin Pathol 1994; 102: 158-
62. 
[45]  DeSombre ER, Thorpe SM, Rose C, et al. Prognostic usefulness of 
estrogen receptor immunocytochemical assays for human breast 
cancer. Cancer Res 1986; 46: 4256s-4264s. 
[46]  Esteban JM, Ahn C, Battifora H, Felder B. Predictive value of 
estrogen receptors evaluated by quantitative immunohistochemical 
analysis in breast cancer. Am J Clin Pathol 1994; 102: S9-12. 
 
 
Received: October 4, 2009  Revised: November 2, 2009  Accepted: November 14, 2009 
 
© Prasad et al.; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc 
/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. 
 
 